Moderna

Moderna loses bid to shift liability in COVID-19 vaccine patent case

By Blake Brittain (Reuters) – Despite the backing of the U.S. government, Moderna Inc on Friday failed to persuade a federal judge it should not have to face a patent lawsuit over…

Pfizer, Moderna hit with new Alnylam patent lawsuits over COVID-19 vaccines

Moderna loses bid to shift liability in COVID-19 vaccine patent case

Moderna to make milestone payments to NIH for COVID vaccine

Moderna generates $18.4 billion in COVID vaccine sales in 2022

Moderna Suing Pfizer For COVID-19 Vaccine Patent Infringement

Moderna CEO: COVID variant vaccine to be ready for shipping in August

U.S. FDA advisers back Moderna COVID-19 vaccine for small children

Moderna to invest 500 million euros in Spain, PM Sanchez says

U.S. FDA sets June meeting dates for Moderna, Pfizer small children COVID-19 vaccines

Moderna names Jorge Gomez as new CFO

Moderna raises full-year COVID vaccine sales forecast to $21 billion

Moderna to develop mRNA-based shingles vaccine

Trial for first Omicron specific booster shot started by Moderna

Pfizer, Moderna shots safe during in vitro fertilization; healthy gut bacteria may help prevent long COVID

Moderna CEO says you’re going to need a fourth vaccination next fall and more after that

Moderna Is Developing A Single-Dose Vaccine That Combines COVID-19 And Flu Boosters

Fauci: CDC never said vaccinated people should ditch their facemasks